2007 National Healthcare Quality Report: Data Tables Appendix--Table 1.53c

You Are Here: AHRQ Home > Quality Assessment > Measuring Healthcare Quality > National Healthcare Quality & Disparities Reports, 2007 > Quality Report: Data Tables Appendix

Table 1.53c
Percent of heart failure patients with left ventricular systolic dysfunction prescribed ACE inhibitor or angiotensin receptor blocker at discharge, all payers, by State, 2004 and 2006

State	2006	2004
State	Percent^a	Percent^a
Total^b	81	74
Alabama	77	73
Alaska	88	75
Arizona	82	76
Arkansas	77	64
California	83	73
Colorado	86	78
Connecticut	86	80
Delaware	81	73
District of Columbia	80	85
Florida	82	73
Georgia	81	74
Hawaii	82	70
Idaho	74	72
Illinois	83	76
Indiana	81	72
Iowa	82	74
Kansas	73	67
Kentucky	78	65
Louisiana	78	73
Maine	86	85
Maryland	85	78
Massachusetts	85	82
Michigan	84	77
Minnesota	84	76
Mississippi	76	66
Missouri	81	76
Montana	83	69
Nebraska	75	75
Nevada	82	80
New Hampshire	87	76
New Jersey	87	78
New Mexico	78	65
New York	85	78
North Carolina	80	74
North Dakota	72	73
Ohio	83	76
Oklahoma	76	75
Oregon	83	79
Pennsylvania	79	68
Rhode Island	86	84
South Carolina	86	72
South Dakota	80	72
Tennessee	79	69
Texas	83	73
Utah	78	78
Vermont	87	67
Virginia	83	73
Washington	84	70
West Virginia	79	70
Wisconsin	84	80
Wyoming	78	79

^a State average percent precalculated and supplied as part of the Hospital Compare database. The 2004 data reflect care for the period January to June 2004; the 2006 data reflect care for the period April 2005 to March 2006.

^b Estimates are the means of reporting States.

Key: ACE: angiotensin converting enzyme.

Source: Centers for Medicare & Medicaid Services, Hospital Compare.